Early Kidney Damage Markers after Deferasirox Treatment in Patients with Thalassemia Major: A Case-Control Study

Early Kidney Damage Markers after Deferasirox Treatment in Patients with Thalassemia Major: A Case-Control Study

Background. The life of patients with β-thalassemia major depends on blood transfusion. Regular blood transfusion leads to hemosiderosis in their main organs. The aim of this study was to compare the effects of deferasirox and deferoxamine on renal damage in patients with β-thalassemia major. Method...

Full description

Bibliographic Details
Main Authors: Hamidreza Badeli, Adel Baghersalimi, Sajjad Eslami, Farshid Saadat, Afagh Hassanzadeh Rad, Rokhsar Basavand, Soghra Rafiei Papkiadeh, Bahram Darbandi, Wesam Kooti, Ilaria Peluso
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Oxidative Medicine and Cellular Longevity
Online Access:http://dx.doi.org/10.1155/2019/5461617

Internet

http://dx.doi.org/10.1155/2019/5461617

Similar Items